Nutrition approach to CV disease gains weight

The risk factors and symptoms associated with peripheral vascular
disease and intermittent claudication can be reduced by better
nutrition, say Spanish researchers in a study published in this
month's Journal of Nutrition.

The benefits of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), oleic acid, folic acid, and vitamins A, B-6, D, and E for cardiovascular health have been well documented. The researchers set out to examine the effects of low dose supplementation in a group of 60 men suffering from peripheral vascular disease and intermittent claudication.

Peripheral vascular disease is a generic term used for circulation disorders affecting blood vessels outside the heart and brain. More specifically, peripheral artery disease is a condition whereby the arteries that carry blood to the extremities become clogged with cholesterol and blood flow is restricted.

Intermittent claudication is a symptom of peripheral artery disease. The clogged arteries cannot deliver enough oxygenated blood to active muscles during exercise, causing the muscles to cramp up and the sufferer to experience shooting pains that subside only after they stop exercising. The participants were randomly assigned to one of two groups. One group consumed 500 mL each day of a fortified dairy product containing EPA, DHA, oleic acid, folic acid and vitamins A, B-6, D, and E.

The other consumed 500 mL/d of semi-skimmed milk with added vitamins A and D.

The groups received lifestyle and dietary recommendations, and continued to consume their regular diet as well as the products.

The benefits of supplementation were measured by blood extractions and clinical explorations after three, six, nine and 12 months, and compared to baseline readings taken before the start of the study.

The researchers found that total cholesterol and apolipoprotein B concentrations decreased in the supplement group, and total homocysteine decreased in those patients who had high initial concentrations.

The supplemented subjects were also able to walk for longer distances that the control group before the onset of claudication.

According to the researchers, the results provide "new evidence of the potential role of nutrition in the reduction of PVD-IC symptoms"​.

Related topics Research Cardiovascular health

Related news

Show more

Related products

show more

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Sports Nutrition Formulations Re-imagined

Sports Nutrition Formulations Re-imagined

Content provided by Gencor | 30-Sep-2024 | White Paper

Gencor offers scientifically proven sports nutrition solutions intentionally designed for optimal performance and recovery for any level of athletic activity,...

Tackling Metabolic Health with HIMABERB® Berberine

Tackling Metabolic Health with HIMABERB® Berberine

Content provided by Pharma Base S.A. | 18-Sep-2024 | White Paper

Metabolic health is a prevalent and rapidly growing global challenge. In recent years, there has been mounting clinical evidence to support the use of...

UthPeak® NMNH Million Dollars Subsidy Program

UthPeak® NMNH Million Dollars Subsidy Program

Content provided by Effepharm Ltd | 29-Jul-2024 | Product Brochure

Introducing the UthPeak® Million Dollar Campaign! Unlock the full marketing potential of the groundbreaking reduced NMN, NMNH.

Related suppliers

Follow us

Products

View more

Webinars